A short rendezvous with Dr Rahul Bhargava, Principal Director & Chief BMT, Fortis Memorial Research Institute, Gurugram, unraveled the mysteries of India’s CAR T-cell Therapy. NexCAR19, the indigenously developed CAR T-cell therapy, has revolutionized the way we view cancer treatment in India. Earlier, we would only talk about treating cancer by managing its symptoms.